The December content release includes the following updates:
Year-To-Date EMA and FDA statistics:

• 133,152 new pages
• 6,809 new documents
• 228,462 new extracted PK data observations
• 102,532 new extracted safety data observations
• 59 new drugs

Addition of CBER biologics content:

• 9,077 new pages
• 495 new documents
• New data on 51 CBER biologics drugs

FDA Approval Packages:

• 9 new drugs:
  • Brentuximab Vedotin
  • Crizotinib
  • Emtricitabine; Rilpivirine; Tenofovir Disoproxil Fumarate
  • Vemurafenib
  • Diphtheria and Tetanus Toxoids; Acellular Pertussis Adsorbed; Inactivated Poliovirus Vaccine Combined
  • Diphtheria and Tetanus Toxoids; Acellular Pertussis; Poliomyelitis (Inactivated); Haemophilus B Conjugate Vaccine
  • Fibrinogen
  • Smallpox (Vaccinia) Vaccine, Live
  • Typhoid VI Polysaccharide Vaccine
• 1555 new FDA Approval Documents
• 32,540 new pages of FDA Approval Documents

Extracted PK data observations:

• 32,171 new extracted PK data lines

Extracted Safety data observations:

• 36,502 new extracted safety data lines

Published Toxicity Database:

• 1,370 new safety records

AERS (post-marketing) reports:

• 941 new reports

The new totals for PharmaPendium are:

• 1,538,594 pages of FDA Approval documents (Including FDA Classic Collection)
• 65,450 documents of FDA Approval documents (Including FDA Classic Collection)
• 4102 drugs with data in PharmaPendium
• 1,079,653 extracted safety data lines
• 1,256,587 extracted PK data lines
• 4,131,239 AERS (post-marketing) reports
• 4,691 documents / 82,421 pages of EMA Approval documents
• 10,175 documents / 417,321 pages of FDA Advisory Committee Meeting documents
• 10,906 documents / 308,015 pages of FDA Classic Collection